Eurofins to Acquire DNA Diagnostics Center to Grow Consumer Genetic Testing Capabilities

Eurofins Scientific announced that its subsidiary Eurofins Clinical Testing US Holdings, Inc. agreed to acquire DNA Diagnostics Center (“DDC”), a leader in consumer genetic testing. DDC anticipates delivering revenues of over $55 million in 2021.

DDC was founded on the premise that technological advancements in DNA testing should translate into services that are accessible to everyone. The company provides comprehensive consumer and legal DNA testing services for paternity and family relationships, fertility, lifestyle, veterinary, and forensics. DDC is an established and trusted consumer-focused testing laboratory, with an extensive and global distribution network.

Eurofins believes that consumer genetic testing, to support personalized lifestyle and health awareness is a significant growth opportunity, and this acquisition will accelerate Eurofins’ strategy to expand further into this market. DDC has a highly successful and growing test and product menu and will benefit from Eurofins access to additional markets. We also expect leverage from DDC distribution and sales of existing Eurofins testing capabilities into the consumer market for both genetic and other health and wellness-related tests.

“Eurofins looks forward to welcoming DNA Diagnostics Center and its highly qualified and dedicated team to Eurofins,” commented Dr. Gilles Martin, Eurofins CEO. “This acquisition reinforces our commitment to provide testing solutions to answer critical health, wellness and genetic questions for consumers.”